Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: BUPRENORPHINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for buprenorphine submitted by Teva Pharmaceuticals USA, Inc., indicating an approved update to the product by the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)